XCNQTHC
Market cap2mUSD
Jan 31, Last price
0.02CAD
Name
THC Biomed Intl Ltd
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
191.75%
Revenues
0k
-100.00%
Net income
0k
P
CFO
0k
P
Profile
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | 2017‑07 | 2016‑07 | 2015‑07 | |
| Income | |||||||||
Revenues | 3,340 -11.51% | ||||||||
Cost of revenue | 5,593 | ||||||||
Unusual Expense (Income) | |||||||||
NOPBT | (2,253) | ||||||||
NOPBT Margin | |||||||||
Operating Taxes | (632) | ||||||||
Tax Rate | |||||||||
NOPAT | (1,621) | ||||||||
Net income | (2,434) -64.11% | ||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 15 | ||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 3,519 | ||||||||
Long-term debt | 1,179 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 4,214 | ||||||||
| Cash flow | |||||||||
Cash from operating activities | (1,857) | ||||||||
CAPEX | (160) | ||||||||
Cash from investing activities | 2,480 | ||||||||
Cash from financing activities | (250) | ||||||||
FCF | 10,887 | 1,736 | |||||||
| Balance | |||||||||
Cash | 484 | ||||||||
Long term investments | |||||||||
Excess cash | 317 | ||||||||
Stockholders' equity | 6,933 | ||||||||
Invested Capital | 9,144 | ||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 163,902 | ||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (1,324) | ||||||||
EV/EBITDA | |||||||||
Interest | 501 | ||||||||
Interest/NOPBT | |||||||||